Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village. Ahmed OA, Safwat E, Khalifa MO, Elshafie AI, Fouad MHA, Salama MM, Naguib GG, Eltabba…

Integrated Models of Care for People Living with Hepatitis C Virus and a Substance Use Disorder: Protocol for a Systematic Review. Ti L, Parent S, Socías ME. JMIR Res Protoc. 2018 May 9;7(5):e122. doi: 10.2196/resprot.9532. https://www.ncb…

CROI 2018: Highlights of Viral Hepatitis. Luetkemeyer AF, Wyles DL. Top Antivir Med. 2018 May;26(1):30-38. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963935/

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection Ramos-Casals, Manuel et al. Journal of Hepatology , Volume 66 , Issue 6 , 1282 - 1299  https://www.journal-of-hepatology.e…

WHO: Factsheet Hepatitis C (WHO, 02.10.2017) http://www.who.int/en/news-room/fact-sheets/detail/hepatitis-c

Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases Negro, Francesco Journal of Hepatology , Volume 61 , Issue 1 , S69 - S78  https://www.journal-of-hepatology.eu/article/S0168-8278(14)00542…